Myofascial pain syndrome of the neck
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 20 years or older with neck pain and upper back pain with pain as the main complaint who visited Kimura Pain Clinic or Isesaki Municipal Hospital from the date of approval by the Ethics Committee to March 31, 2026, and who have been diagnosed with MPS and have complaints of pain with a maximum VAS of 30 mm or more during movement.
Exclusion criteria
Exclusion criteria: Patients who cannot give consent for this study will be excluded from the study. Patients who have difficulty with the withdrawal of anticoagulant/antithrombotic drugs, patients with bleeding tendencies, and patients with signs of infection at the site where fascia hydrorelease is to be performed will be excluded from the study. Patients will also be excluded from the study if it is difficult to assess blood flow in the transverse carotid artery using ultrasound equipment. Patients scheduled to undergo a fascia hydrorelease at another site during the study period as treatment will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The patient is evaluated by listening to the pain Visual Analog Scale (VAS) at rest and during neck movement to see if neck pain improves by performing a fascia hydrorelease targeting the transverse cervical artery or the dorsal scapular artery. | — |
Secondary
| Measure | Time frame |
|---|---|
| We will evaluate whether fascia hydrorelease targeting the transverse carotid artery or the dorsal scapular artery improves blood flow by analyzing ultrasound findings and local temperature changes in the affected area. A questionnaire will be used to evaluate whether or not the activities of living (ADL) are improved by fascia hydrorelease. | — |
Countries
Japan
Contacts
Isesaki Municipal Hospital Department of Anesthesiology